Sanofi-aventis launches M&A syndication
French pharmaceutical firm Sanofi-aventis is launching a $15bn loan into syndication after initiating an $18.5bn hostile bid for US biotech firm Genzyme on Monday. BNP Paribas, JPMorgan and Société Générale have underwritten the facility, which is not expected to be widely syndicated but targeted to a few relationship lenders. To find out more, read EuroWeek this Friday.
Nina Flitman +44 20 7779 7320
Click here for previous coverage...